General description
INN
Metronidazole
Medicine type
Chemical agent
Antibiotic groups
EML status history
First added in 1977
(TRS
615)
for
Amoebiasis
Added in 1979
(TRS
641)
for
Bacterial infection of unspecified site
Removed in 2017
(TRS
1006)
for
Bacterial infection of unspecified site
Added in 2017
(TRS
1006)
for
Intestinal infections due to Clostridioides difficile
Added in 2017
(TRS
1006)
for
Trichomoniasis
Added in 2021
(TRS
1035)
for
Necrotising fasciitis
Added in 2023
(TRS
1049)
for
Peritonitis
Added in 2023
(TRS
1049)
for
Peritoneal abscess
Added in 2023
(TRS
1049)
for
Other specified prophylactic measures
Wikipedia
DrugBank
Recommendations
Section
Access group antibiotics
- Oral > Liquid: 200 mg per 5 mL (as benzoate)
- Oral > Solid: 200 to 500 mg tablet
- Parenteral > General injections > unspecified: 500 mg per 100 mL in vial Injection
- Local > Rectal > Suppository: 500 mg; 1 g
- Parenteral > General injections > unspecified: 500 mg per 100 mL in vial
- Oral > Solid > tablet: 500 mg; 200 mg; 250 mg; 400 mg
- Oral > Solid > tablet: 200 mg; 250 mg; 400 mg; 500 mg
Indications
Other indications
Section
Antiamoebic and antigiardiasis medicines
- Oral > Liquid: 200 mg per 5 mL (as benzoate)
- Parenteral > General injections > unspecified: 500 mg in 100 mL vial
- Oral > Solid > tablet: 200 mg; 250 mg; 400 mg; 500 mg
Indications